Monday, August 31, 2026

Your Angel Mandate Has an Expiration Date. Here's How to Renegotiate It

Zoom out from any single company, and an angel's career follows a fairly consistent shape in three time-bound phases for any invested cohort.






Phase

Typical duration

What's actually happening

Active deployment

Year 0 - 4 

Capital goes out. A diversified angel typically writes 15–30 checks in this window.

Management & follow-on

Year 0 - 6 years

Focus shifts to mentoring existing founders, monitoring the portfolio, and deciding where to defend a position with follow-on capital.

Waiting & liquidity

Year 3 to 15+ 

Most of the calendar. Angel-backed companies take roughly 9–11 years, on average, to reach an acquisition or IPO, so even a short active window is followed by a long one spent simply waiting for an outcome.


Two structural forces compress the active window. One is capital: angels invest personal money, and once the "high-risk" allocation is deployed, new checks wait on prior ones returning capital. The other is fatigue: with 60 - 70% of individual investments returning zero and full-cycle exits often a decade out,  many solo angels burn out and step back after ten to fifteen years. 


Somewhere around Series A, the governance picture most angels have been informally operating on disappears and a real one replaces it. It's worth spelling out what actually changes, because the instinct to keep doing what worked until then is usually the wrong one.


A few things happen at once. The company converts from SAFEs to preferred stock and a board gets formally constituted. Typically the lead Series A investor takes a seat, sometimes a second institutional investor, hopefully an independent director. Board members now carry fiduciary duties such as care and loyalty to the company and its shareholders as a whole. This is a materially different obligation than an angel casually advising a founder. Information starts flowing through formal channels: board decks, monthly or quarterly board packets, sometimes committees for compensation or audit. And the founder's time, which used to be available for an unscheduled call with a helpful early check-writer, now is formally claimed by the people with a board seat and a fiduciary reason to use it.


Most angels do not end up with a seat at that table. Check sizes at seed are usually too small relative to the Series A lead to justify one, and a crowded cap table of individual board seats is exactly what a new institutional investor will resist. So the realistic question isn't "how do I get a board seat", it is how to define a role that still adds value. In practice, that tends to land in one of three places:


  • A board observer seat, negotiated into the side letter at the seed round rather than requested after the fact. It carries forward, gives visibility into board-level decisions without a fiduciary vote, and is far easier to secure before the cap table gets competitive.

  • A formal advisory agreement, with an explicitly scoped mandate and sometimes a modest equity refresh. This is the mechanism by which the "audit your superpower" boundary from the seed stage gets written down rather than left as an informal understanding.

  • A narrower Strategic Connector role, where the angel steps back from day-to-day operating involvement because the company now has real executives and a real board doing that job, and the highest-value contribution left is network access when it matters: the enterprise intro, the next-round investor, the exec hire.


This is more of a recalibration of the role than a downgrade. The Operational Co-Pilot role that was genuinely useful when a company had no VP of Sales and no board is often actively unhelpful once it has both. The angels who navigate this well are the ones who treat the arrival of a board as a scheduled renegotiation of their own mandate and not a demotion.

These transitions happen because the angel decided, at each stage, what role was actually useful and asked for it. The angels who stay relevant longest are the ones who keep renegotiating the mandate as the company's governance catches up with its ambition.


No comments:

Post a Comment